Real-time PCR analysis, using 10 pairs of matched breast cancer and normal tissues, showed that NSUN2 was overexpressed (P<0.05) in 100% (10/10) of breast cancer patients, which is consistent with the data obtained from Oncomine database (Supplementary Figures 1 and 2A). Here, NSUN2 is linked to breast cancer.